Genetic study reveals link between Polynesian ancestry and higher risk for obesity, T2DM, heart failure in Native Hawaiians
WEDNESDAY, Feb. 24, 2021 (HealthDay News) — Polynesian ancestry in Native Hawaiians seems to be associated with an increased risk for obesity, type 2 diabetes, and heart failure, according to a study published online Feb. 11 in PLOS Genetics.
Hanxiao Sun, from the University of Southern California in Los Angeles, and colleagues used genome-wide single-nucleotide polymorphism array data for about 4,000 Native Hawaiians from the Multiethnic Cohort to study genetic factors at both the chromosomal and subchromosomal scales.
The researchers found that per 10 percent increase in global Polynesian genetic ancestry, there was an 8.6 and 11.0 percent increase in the odds of diabetes and heart failure, respectively, and a 0.059 standard deviation increase in body mass index after attempting to adjust for nongenetic covariates. A chr6 region associated with type 2 diabetes was identified when testing the association of local Polynesian ancestry with the risk for disease or biomarkers. In individuals of Polynesian ancestry, this association was driven by a uniquely prevalent variant. However, in an independent Polynesian cohort from Samoa, this association could not be replicated due to the small size of the replication cohort.
“Our results suggest future studies could identify population-specific genetic susceptibility factors that may elucidate underlying biological mechanisms and [reduce] the disparity in disease risks in Polynesian populations,” the authors write.
Pulse Oximetry-Based Scoring May Miss Sleep Apnea Events in Black Patients
High Indoor Radon Levels Tied to Higher Risk for Heart Failure
Study Looks at Approaches to Prescribing Obesity Medications for Older Adults
Few Meet Major Clinical Response Criteria After Treatment Escalation for Lupus
Postoperative Complications Elevated for Patients With Systemic Lupus Erythematosus
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions
Low Hydroxychloroquine Intake, Blood Levels Linked to ASCVD Risk in Lupus
Anifrolumab Tied to Lower Hospitalization, Infection Risk in Lupus